May 20, 2004BMJOpen Access

Primary angioplasty should be first line treatment for acute myocardial infarctionAGAINST

View Full Paper

Ask AI

Bookmark

Why the study?

Does primary angioplasty reduce mortality compared to thrombolysis in patients with acute ST elevation myocardial infarction?

Population

Patients with acute ST elevation myocardial infarction

Comparison

Primary angioplasty vs Thrombolysis (fibrinolytic therapy)

Design

Editorial

Authors

KCKevin S. ChannerElectrophysiology

Discussion

Member takes

Implication

This debate highlights that while primary angioplasty is superior to thrombolysis in trial settings, logistical delays in real-world implementation may negate its mortality benefits.

Structured PICO

Does primary angioplasty reduce mortality compared to thrombolysis in patients with acute ST elevation myocardial infarction?

Population

Patients with acute ST elevation myocardial infarction

Intervention

Primary angioplasty

Comparator

Thrombolysis (fibrinolytic therapy)

Outcome

Mortalityhard clinical

This debate highlights that while primary angioplasty is superior to thrombolysis in trial settings, logistical delays in real-world implementation may negate its mortality benefits.

Cite This Study

Kevin S. Channer (2004) studied this question.

synapsesocial.com/papers/6a8c3faeb676b7d1a2fba04c https://doi.org/10.1136/bmj.328.7450.1256

View Full Paper

Ask AI

Bookmark

Implication

This debate highlights that while primary angioplasty is superior to thrombolysis in trial settings, logistical delays in real-world implementation may negate its mortality benefits.

Primary angioplasty should be first line treatment for acute myocardial infarctionAGAINST

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Primary angioplasty should be first line treatment for acute myocardial infarctionAGAINST

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider